Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age15-100
SponsorAmivas Inc.

About this trial

This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.

Eligibility criteria

Qualifiers

Patient received IV Artesunate

Patient was pregnant while receiving IV Artesunate

Patient was at least 15 years of age

Patient or legal guardian/representative gave consent for the study and to collect data from her physicians

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators